Skip to menu Skip to content Skip to footer
  • UQ Home
  • Contacts
  • Study
  • Maps
  • News
  • Events
  • Library
  • Give now
  • my.UQ
The University of Queensland
School of Biomedical Sciences School of Biomedical Sciences
Site search
Site search
Menu
  • Home
  • About
    • Head of School's welcome
    • Strategic Intent
    • Global strategy
    • Committees
    • News
    • Events
  • Study
    • Undergraduate
    • Higher Degrees by Research
    • Professional development
    • Honours
    • Teaching disciplines
  • Research
    • Research themes
    • Research groups
    • Early career researchers
    • Research capabilities
  • Facilities
    • Analytical Facility
    • Gross Anatomy Facility
    • Histology Facility
    • Integrated Pathology Learning Centre
    • Integrated Physiology Facility
    • Microscopy and Image Analysis Facility
    • Teaching facilities
    • Viral Vector Core
  • Student support
    • Resources
    • First year study sessions
    • Research student resources
    • Lavidis Grant
    • Student-staff partnerships
  • Engagement
    • Donate
    • Work with us
    • Body Donor Program
    • Industry partnerships
    • Primary and high school activities
  • Our people
  • Contact

Grants

  1. Home
  2. Research
  3. Research groups
  4. Centre for Integrated Preclinical Drug Development
  • Novel non-opioid analgesics

    (2018–2020) NHMRC Development Grant

  • The impact of extracorporeal membrane oxygenation (ECMO) on the activities of drug enzymes that affect the pharmacokinetics and therapeutic outcomes of clinically important drugs

    (2017–2018) Prince Charles Hospital Foundation

  • Novel prolonged-release polymeric microparticles for relief of intractable cancer-related pain

    (2016–2018) NHMRC Project Grant

  • Novel Pain therapeutics discovery: Probing molecular mechanisms

    (2016) NHMRC Equipment Grant

  • ACRF Facility for Molecular Imaging Agents in Cancer (AFMIAC)

    (2015–2022) Australian Cancer Research Foundation

  • INK-004 Preliminary assessment of the analgesic efficacy of one test item following intrathecal bolus administration in a rat model of peripheral neuropathic pain

    (2015–2016) UniQuest Pty Ltd

  • Novel analgesics for improved relief of cancer induced bone pain

    (2015) UQ Collaboration and Industry Engagement Fund

  • Developing subtype-selective blockers of acid-sensing ion channels for treating peripheral pain

    (2014–2017) NHMRC Project Grant

  • Translating Health Discovery (THD) - NCRIS 2013/2015/2016-17 (administered by Therapeutic Innovation Australia (TIA))

    (2014–2017) Therapeutic Innovation Australia Limited

  • PHG-003 - Preparation of manuscript encompassing the data generated in studies PHG-001 and PHG-002 for publication in an international peer-reviewed journal

    (2014–2015) UniQuest Pty Ltd

  • Efficacy Profiling Innovation in Novel Pain Therapeutics Discovery

    (2013–2016) ARC Linkage Projects

  • Investigations into the pain relief properties of Komipharm's test compound

    (2013–2016) UniQuest Pty Ltd

  • Oral EMA401 mode of action study in a rat model of post-herpetic neralgia (PHN)

    (2013–2015) Spinifex Pharmaceuticals Pty Ltd

  • High throughput electrophysiology platform

    (2013) UQ Major Equipment and Infrastructure

  • Translating health discoveries into products

    (2011–2015) Queensland Government Smart Futures Co-Investment Fund

  • Therapeutic Innovation Australia - Queensland node (Source of funds: EIF)

    (2011–2014) Therapeutic Innovation Australia Limited

  • Development of chaperonin 10-based second generation biopharmaceuticals for treatment of inflammatory diseases

    (2010–2013) ARC Linkage Projects

  • Novel polymeric microparticles for slow-release intrathecal delivery of analgesics

    (2010–2013) ARC Linkage Projects

  • Development of high throughput in-vitro test methods for screening sensitization potential of industrial chemicals

    (2010–2012) UQ Collaboration and Industry Engagement Fund

  • Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations

    (2010) UQ Major Equipment and Infrastructure

  • High content imaging analysis for bioactive and novel therapeutic target evaluation

    (2010) UQ Major Equipment and Infrastructure

  • Alzheimer's disease: Novel MRI Biomarkers for Clinical Diagnosis and Translational Studies

    (2009–2013) Queensland Government Smart State National and International Research Alliances Program

  • Systematic evaluation of whether in vitro methods can predict in vivo opioid analgesic efficacy, safety and teolerability

    (2009–2010) Alchemia Pty Ltd

  • Investigation of the relationship between cytokine levels and opioid analgesics in patients with chronic non-cancer pain receiving long term intrathecal opioid therapy for pain management

    (2008) Gallipoli Research Foundation

  • Novel therapeutic for treating painful diabetic neuropathy

    (2008) Diabetes Australia Research Trust

  • Systematic evaluation of whether in vitro methods can predict in vivo opioid analgesic efficacy, safety and tolerability

    (2006–2009) ARC Linkage Projects

  • Investigation of whether a small dose of Oxycodone enhances the efficacy and/or tolerability of orally administered pregabalin in patients with either post-herpetic neuralgia (PHN) or painful diabetic

    (2006–2007) Gallipoli Research Foundation

  • Advanced Cell Labelling and Imaging Facility

    (2006) ARC Linkage Infrastructure, Equipment and Facilities

  • NHMRC_Equipment Grant = DSI Telemetry System

    (2005) NHMRC Equipment Grant

  • NHMRC_Equipment Grant_HLTH_Pharmacy

    (2004–2005) NHMRC Equipment Grant

  • The analgesic evaluation of novel natural products from the Australian plant Barringtonia acutangula

    (2004–2005) Griffith University

  • Malvern Zetasizer 3000HS

    (2003) NHMRC Equipment Grant

  • Pharmacological investigation of the toxicological effects of high doses of systemic morphine

    (2002–2003) Queensland Cancer Fund

  • Lipid and liposaccharide based drug delivery systems

    (2001–2004) Wellcome Trust

  • Prevention of chronic complications in the STZ-diabetic rat

    (2001–2002) Mayne Bequest Fund

  • A biohazard laminar flow hood for neuronal cell cultures:partial cost recovery from emergency purchase

    (2001) Brain Research Fund

  • Efficacy of oxycodone for relief of neuropathic pain

    (2000) Pharmaceutical Society of Australia

  • Efficacy of oxycodone relative to morphine for the relief of neuropathic pain in rats

    (2000) Brain Research Fund

  • A novel liposaccharide based system for drug/peptide delivery

    (1999–2002) Wellcome Trust

  • The use of fluorescence microscopy to investigate the role of the calcium pump in disease and the mechanism of excitatory side effects by high dose morphine

    (1999) Ramaciotti Foundation

  • M3G: Further Studies of its CNS Pharmacology

    (1998–2000) NHMRC Project Grant

  • Further investigation of morphine 3-glucuronide's role in the dose-limiting excitatory side-effects of morphine administered chronically to cancer patients

    (1998–1999) Queensland Cancer Fund

  • Evaluating morphine for intra-articular analgesia in dogs using forceplate platform technology

    (1996) John & Mary Kibble Trust

  • Functional characterisation of opioid binding sites in rat airways

    (1996) ARC Australian Research Council (Small grants)

  • Investigation of the CNS mechanisms involved in the excitatory side-effects of Morphine in cancer pain management

    (1995–1997) Queensland Cancer Fund

  • Sustained release of novel injectable analgesic agents - a pharmacological evaluation in rats

    (1995) ARC Australian Research Council (Small grants)

  • Available student projects
  • Grants
  • Partners
  • Publications
  • Research
© The University of Queensland
Enquiries: +61 7 3365 1111   |   Contact directory
ABN: 63 942 912 684   |   CRICOS Provider No: 00025B
Emergency
Phone: 3365 3333
Privacy & Terms of use   |   Feedback   |   Updated: 26 Apr 2019
Login